Big PFS Improvement in Highly Mutated CRC With Dual Immunotherapy
(MedPage Today) -- SAN FRANCISCO -- Frontline dual immunotherapy significantly improved progression-free survival (PFS) versus chemotherapy in microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) metastatic colorectal cancer... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 22, 2024 Category: Gastroenterology Source Type: news

'See you on the other side!' Harrowing last TikTok posts of British girl, 20, who died writhing in agony in a Belgrade hospital after undergoing £2,500 weight loss surgery in cut-price Turkish clinic 'because she didn't want to wait for NHS treatment'
Morgan Ribeiro, 20, had flown to Turkey with her boyfriend for a £2,500 gastric sleeve operation earlier this month as she didn't want to be placed 'on an NHS waiting list for years.' (Source: the Mail online | Health)
Source: the Mail online | Health - January 22, 2024 Category: Consumer Health News Source Type: news

This BioPharma Could Be First To Market With Its Celiac Therapy
James Sapirstein, Chairman, President & CEO of First Wave BioPharma, Inc. FWBI was recently a guest on Benzinga’s All-Access. First Wave BioPharma is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.…#jamessapirstein #benzingasallaccess #firstwavebiopharma (Source: Reuters: Health)
Source: Reuters: Health - January 22, 2024 Category: Consumer Health News Source Type: news

How to Optimize EHR Use in Gastroenterology Practices How to Optimize EHR Use in Gastroenterology Practices
Implementing strategies to improve electronic health record use can save time, enhance the doctor-patient relationship, and reduce burnout.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 22, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news

No Compelling Evidence of Pancreatic Cancer Risk With GLP-1s No Compelling Evidence of Pancreatic Cancer Risk With GLP-1s
Up to 7 years treatment with GLP-1 receptor agonist in patients with type 2 diabetes didn ' t seem to increase pancreatic cancer risk in a large population-based cohort study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 22, 2024 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news

Sagimet's Shares Hit New High as Fatty Liver Disease Drug Shows Promise in Study Sagimet's Shares Hit New High as Fatty Liver Disease Drug Shows Promise in Study
Sagimet Biosciences said on Monday its experimental drug to treat a fatty liver disease significantly reduced the symptoms in a mid-stage study, sending the drug maker ' s...Reuters Health Information (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 22, 2024 Category: Internal Medicine Tags: Gastroenterology Source Type: news

Cancer Deaths on Decline, But New Cases to Hit Record High Cancer Deaths on Decline, But New Cases to Hit Record High
CRC is now the leading cause of cancer deaths in men under age 50 and the second in women under 50, according to the latest ACS annual report on cancer trends.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 22, 2024 Category: Gastroenterology Tags: Hematology-Oncology Source Type: news

The Case for Biomarker Testing in Gastroesophageal Cancer The Case for Biomarker Testing in Gastroesophageal Cancer
To take advantage of the latest targeted therapies in gastroesophageal cancer, physicians needed to identify patients who will benefit, but biomarker testing in this population continued to lag.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 22, 2024 Category: Pathology Tags: Hematology-Oncology Source Type: news

New Standard for Unresectable Hepatocellular Carcinoma?
(MedPage Today) -- SAN FRANCISCO -- After more than 20 years of trying, systemic therapy for unresectable liver cancer has improved outcomes with transarterial chemoembolization (TACE), a randomized trial showed. Patients who received durvalumab... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 21, 2024 Category: Gastroenterology Source Type: news

HAIP Chemo Offers OS Advantage in Advanced Intrahepatic Cholangiocarcinoma
(MedPage Today) -- SAN FRANCISCO -- Hepatic arterial infusion pump (HAIP) chemotherapy with floxuridine significantly improved overall survival (OS) in patients with advanced intrahepatic cholangiocarcinoma (iCCA), according to results from a... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 21, 2024 Category: Gastroenterology Source Type: news

Radioligand Gets Big Win in High-Grade GEP Neuroendocrine Tumors
(MedPage Today) -- SAN FRANCISCO -- Adding a radioligand to standard therapy almost tripled median progression-free survival (PFS) in untreated high-grade gastroenteropancreatic neuroendocrine tumors (GEP-NETs), a randomized trial showed. Median... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - January 21, 2024 Category: Endocrinology Source Type: news

Novartis Lutathera ® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced…
In the Phase III NETTER-2 trial, Lutathera plus octreotide LAR significantly extended median PFS to 22.8 months vs. 8.5 months with high-dose octreotide LAR in patients with newly diagnosed grade 2 and 3 advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)1 • NETTER-2 is the first and…#phaseiiinetter2 #lar #rlt #novartis #gep #basel #lutathera #lu177 #laralone1 #simronsingh (Source: Reuters: Health)
Source: Reuters: Health - January 20, 2024 Category: Consumer Health News Source Type: news

One man and his extraordinary cellar: the Luigi Veronelli story
The gastronome who reinvented Italian wine died with more than 35,000 bottles in his cellar. Finally, they might get drunk#italian (Source: Reuters: Health)
Source: Reuters: Health - January 20, 2024 Category: Consumer Health News Source Type: news

'I'm a gastroenterologist - this is why you need to stop using your phone while pooping'
Using your phone on the toilet could lead to a painful condition, a doctor has warned. (Source: Daily Express - Health)
Source: Daily Express - Health - January 20, 2024 Category: Consumer Health News Source Type: news

Adding Immunotherapy, Anti-TIGIT in First Line Boosts OS in Esophageal Cancer
(MedPage Today) -- SAN FRANCISCO -- Adding the novel anti-TIGIT monoclonal antibody tiragolumab plus atezolizumab (Tecentriq) to standard first-line chemotherapy significantly improved survival for patients with advanced esophageal squamous cell... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 20, 2024 Category: Gastroenterology Source Type: news